31110500R,RevMAb Biosciences,Rabbit Monoclonal,RevMAb Biosciences,+,兔单克隆,Array.Array.Array蚂蚁淘厂家直采.
Rabbit MonoclonalRevmab/Anti-Cytokeratin 5 Rabbit Monoclonal Antibody, Clone RM226/31-1105-00-R/1.0.ml
RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The recombinant antibodies are developed from a broad range of antigen-...
ProductDetailsProductNameAnti-Cytokeratin5RabbitMonoclonalAntibody[RM226]ProductDescriptionRabbitmonoclonaltoHumanCytokeratin5(CK-5),Keratin-5,CK5CatalogNo.31-1105-00CloneNameRM226ProductDataSheetAnti-Cytokeratin5RabbitMonoclonalAntibodyDataSheetRM226SpecificityRM226reactstoHumanCytokeratin5.Thisantibodymayalsoreacttobovine,mouse,orratCytokeratin,aspredictedbyimmunogenhomology.ImmunogenApeptidecorrespondingtotheC-terminusofHumanCytokeratin5ApplicationImmunohistochemistry(IHC)
WesternBlot(WB)
SpeciesReactivityHuman
(Bovine,Mouse,Rat)ConjugateNoneIntendedUseResearchUseOnly.PropertiesFormLiquidStorageInstructionsStoreat-20.0°CStABIlityStablefor1Yearat-20.0°CfromdateofreceiptStorageBuffer50%Glycerol/PBSwith1%BSAand0.09%sodiumazide
Volume/ItemSize31-1105-00-S:0.1mL
31-1105-00-R:1.0mLPurityProteinAaffinitypurifiedfromananimalorigin–freeculturesupernatantCloneTypeMonoclonalIsotypeRabbitIgGUsageImmunohistochemistry(IHC):1:100-1:400dilution;
WesternBlot(WB):1:1000dilution.
Keywords.ProductImages
ImmunohistochemicalstainingofFFPEhuman
tonsil tissue sections, using Anti-Cytokeratin 5
Rabbit Monoclonal antibody RM226.
ImmunohistochemicalstainingofFFPEhuman
tonsil tissue sections, using Anti-Cytokeratin 5
Rabbit Monoclonal antibody RM226.
WesternBlotofA431celllysatesusingRM226,
showed a band of Cytokeratin 5 expressed in
A431 cells.
RevMAb Biosciences USA, Inc has developed a revolutionary monoclonal antibody generation method which allows development of monoclonal antibodies without generation of hybridoma. The recombinant antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology. This revolutionary method has successfully been applied to develop high quality recombinant rabbit and goat monoclonal antibodies.
